LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

Table 2 Logistics regression of risk factors in predicting paclitaxel plus cisplatin neoadjuvant chemotherapy

	Univariate logistic regression		Multivariate logistic regression
	OR(95%CI)	P	OR(95%CI)	P
CARMN	1.77 (0.58–5.47)	0.312	4.74 (1.13–22.47)	0.039
ER	0.17 (0.058–0.47)	< 0.001	0.20 (0.054–0.65)	0.0097
HER2	2.65 (1.03–7.23)	0.049	4.63 (1.42–17.38)	0.015
Ki67	1.03 (1.01–1.06)	0.014	1.02 (0.99–1.06)	0.12
T stage	0.57 (0.27–1.13)	0.11	0.61 (0.24–1.47)	0.27
N stage	0.64 (0.35–1.15)	0.14	0.80 (0.38–1.60)	0.53

ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2

ISSN: 1756-9966